Uses and sources of data on long-term survival after blood transfusion

Vamvakas, 1994, Mortality after blood transfusion, Transfusion Med Rev, 8, 267, 10.1016/S0887-7963(94)70118-8 Whyte, 1988, The transfused population of Canterbury, New Zealand, and its mortality, Vox Sang, 54, 65, 10.1111/j.1423-0410.1988.tb01618.x Vamvakas, 1994, Long-term survival after blood transfusion, Transfusion, 34, 471, 10.1046/j.1537-2995.1994.34694295060.x Vamvakas, 1997, Length of survival after perioperative transfusion, Transfus Med, 7, 115, 10.1046/j.1365-3148.1997.d01-13.x 1998 Busch, 1995, Declining yield of alanine aminotransferase for screening of blood donors for prevention of post-transfusion hepatitis B and C infection, Transfusion, 35, 903, 10.1046/j.1537-2995.1995.351196110893.x Busch, 1997, Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-period human immunodeficiency virus type 1 infections, Transfusion, 37, 1003, 10.1046/j.1537-2995.1997.371098016437.x AuBuchon, 1997, Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood, Transfusion, 37, 45, 10.1046/j.1537-2995.1997.37197176950.x Kalbfleisch, 1989, Estimating the incubation time, distribution and expected number of cases of transfusion-associated acquired immune deficiency syndrome, Transfusion, 29, 672, 10.1046/j.1537-2995.1989.29890020437.x Peterman, 1987, Estimating the risks of transfusion-associated acquired immune deficiency syndrome and human immunodeficiency virus infection, Transfusion, 27, 371, 10.1046/j.1537-2995.1987.27587320525.x Vamvakas, 2001, 201 Tynell, 2001, Long-term survival in transfusion recipients in Sweden, 1993, Transfusion, 41, 251, 10.1046/j.1537-2995.2001.41020251.x Wells, 2002, Long-term survival after transfusion in the North of England, Vox Sang, 83, 219 Vamvakas, 2002, Four-year survival of transfusion recipients identified by hepatitis C lookback, Transfusion, 42, 691, 10.1046/j.1537-2995.2002.00109.x Titlestad, 2002, Proportion of blood components transfused to patients alive after a defined period, Vox Sang, 83, 220 Vamvakas, 2001, Long-term survival in transfusion recipients in Sweden, 1993, Transfusion, 41, 1173, 10.1046/j.1537-2995.2001.41091173.x Tynell, 2001, Long-term survival in transfusion recipients in Sweden, 1993, Transfusion, 41, 1174, 10.1046/j.1537-2995.2001.t01-1-41091173.x Perkins, 1987, Risk of AIDS for recipients of blood components from donors who subsequently developed AIDS, Blood, 70, 1604, 10.1182/blood.V70.5.1604.1604 Ward, 1989, Natural history of transfusion-associated human immunodeficiency virus, N Engl J Med, 321, 947, 10.1056/NEJM198910053211406 Kolho, 1992, Transmission of HCV infection by RIBA indeterminate and positive blood units, Transfus Med, 2, 243, 10.1111/j.1365-3148.1992.tb00163.x Morris, 1997, Completed hepatitis C lookback in Northern Ireland, Transfus Med, 7, 269, 10.1046/j.1365-3148.1997.d01-44.x Vrielink, 1995, Lookback study of infectivity of anti-HCV ELISA-positive blood components, Lancet, 345, 95, 10.1016/S0140-6736(95)90063-2 Foberg, 1996, Hepatitis C virus transmission, 1998–1991, via blood components from donors subsequently found to be anti-HCV-positive, Scand J Infect Dis, 28, 21, 10.3109/00365549609027144 Norda, 1995, Transfusion of hepatitis C virus by transfusion in Orebro County, Sweden, 1990–1992, Scand J Infect Dis, 27, 449, 10.3109/00365549509047044 Smith, 1997, Outcome of posttransfusion hepatitis C, Q J Med, 90, 587, 10.1093/qjmed/90.9.587 Koermer, 1995, Lookback on hepatitis C-virus infections on HCV-RIBA-2 positive blood donors and their respective recipients, Vox Sang, 69, 78, 10.1111/j.1423-0410.1995.tb00355.x Christensen, 1999, Transfusion-acquired hepatitis C, Transfusion, 39, 188, 10.1046/j.1537-2995.1999.39299154734.x Ayob, 1994, Risk of hepatitis C in patients who received blood from donors subsequently shown to be carriers of hepatitis C virus, Transfus Med, 4, 269, 10.1111/j.1365-3148.1994.tb00263.x Culver, 2000, Evaluation of the effectiveness of targeted lookback for HCV infection in the United States—Interim results, Transfusion, 40, 1176, 10.1046/j.1537-2995.2000.40101176.x Long, 1999, Targeted hepatitis C lookback, Transfusion, 39, 194, 10.1046/j.1537-2995.1999.39299154735.x Menozzi, 2000, HCV lookback in the United States, Transfusion, 40, 1393, 10.1046/j.1537-2995.2000.40111393.x Riley, 1997, Letter notification of blood transfusion recipients (generalized hepatitis C lookback), Transfusion, 37, 99S Donahue, 1991, Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland, Am J Epidemiol, 134, 1206, 10.1093/oxfordjournals.aje.a116023 Seeff, 1992, Long-term mortality after transfusion-associated non-A, non-B hepatitis, N Engl J Med, 327, 1906, 10.1056/NEJM199212313272703 Pillonel, 1995, HTLV-I/II among French blood donors, J Aquir Immune Defic Syndr Hum Retrovirol, 10, 251 Brennan, 1993, Prevalence of antibodies to human T-cell leukemia/lymphoma virus in blood donors in north London, BMJ, 307, 1235, 10.1136/bmj.307.6914.1235 Tynell, 1998, Screening for human T-cell leukemia/lymphoma virus among blood donors in Sweden, BMJ, 316, 1417, 10.1136/bmj.316.7142.1417 Bove, 1987, Lookback, Transfusion, 27, 201, 10.1046/j.1537-2995.1987.27287150201.x Donegan, 1986, Serum antibody positivity in recipients of anti-HIV positive blood, Transfusion, 26, 576 Donegan, 1988, Mass notification of transfusion recipients at risk for HIV infection, JAMA, 260, 922, 10.1001/jama.260.7.922 Menitove, 1986, Status of recipients of blood from donors subsequently found to have antibody to HIV, N Engl J Med, 315, 1095, 10.1056/NEJM198610233151716 Dealler, 1996, A matter for debate, Transfus Med, 6, 217, 10.1111/j.1365-3148.1996.tb00071.x 1998, Guidance for industry 1999, Guidance for industry AuBuchon, 1999, Public health, public trust, and public decision-making, Transfusion, 39, 123, 10.1046/j.1537-2995.1999.39299154724.x Curran, 1984, Acquired immunodeficiency syndrome (AIDS) associated with transfusion, N Engl J Med, 310, 69, 10.1056/NEJM198401123100201 Vamvakas, 2003, Ten-year survival of transfusion recipients identified by hepatitis C lookback, Transfusion, 43, 418, 10.1046/j.1537-2995.2003.00347.x